ES8505650A1 - Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1 - Google Patents

Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1

Info

Publication number
ES8505650A1
ES8505650A1 ES532561A ES532561A ES8505650A1 ES 8505650 A1 ES8505650 A1 ES 8505650A1 ES 532561 A ES532561 A ES 532561A ES 532561 A ES532561 A ES 532561A ES 8505650 A1 ES8505650 A1 ES 8505650A1
Authority
ES
Spain
Prior art keywords
prostaglandin
alkyl ester
fat emulsion
emulsion containing
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532561A
Other languages
English (en)
Spanish (es)
Other versions
ES532561A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Taisho Pharmaceutical Co Ltd
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Taisho Pharmaceutical Co Ltd
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13951830&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8505650(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp Japan, Taisho Pharmaceutical Co Ltd, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Publication of ES532561A0 publication Critical patent/ES532561A0/es
Publication of ES8505650A1 publication Critical patent/ES8505650A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
ES532561A 1983-05-20 1984-05-17 Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1 Expired ES8505650A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58088760A JPS59216820A (ja) 1983-05-20 1983-05-20 プロスタグランジン脂肪乳剤

Publications (2)

Publication Number Publication Date
ES532561A0 ES532561A0 (es) 1985-06-01
ES8505650A1 true ES8505650A1 (es) 1985-06-01

Family

ID=13951830

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532561A Expired ES8505650A1 (es) 1983-05-20 1984-05-17 Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1

Country Status (6)

Country Link
US (1) US4849451A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0132027B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS59216820A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1212324A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3473227D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8505650A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
US5219885A (en) * 1987-02-16 1993-06-15 Froelich Juergen Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
DE3704825A1 (de) * 1987-02-16 1988-08-25 Froelich Juergen Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung
JPS63246330A (ja) * 1987-03-31 1988-10-13 Isamu Koyama 腎臓温阻血障害改善剤
JP2926749B2 (ja) 1989-04-25 1999-07-28 吉富製薬株式会社 プロスタグランジン含有液状組成物
JPH0669966B2 (ja) * 1989-07-05 1994-09-07 株式会社ミドリ十字 血管造影補助剤
JPH03101622A (ja) * 1989-09-11 1991-04-26 Green Cross Corp:The 肝炎予防治療剤
JP2602964B2 (ja) * 1989-10-16 1997-04-23 裕 水島 プロスタグランジン類縁体およびその脂肪乳剤
JP2653245B2 (ja) * 1989-11-27 1997-09-17 日本新薬株式会社 脂肪乳剤
JPH04342530A (ja) * 1991-04-26 1992-11-30 Teijin Ltd ７−フルオロプロスタサイクリン類脂肪乳剤
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
JPH0827018A (ja) 1994-07-22 1996-01-30 Sanwa Kagaku Kenkyusho Co Ltd 生理活性ペプチド又は蛋白質を含有する薬剤組成物
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
WO2004022100A1 (fr) * 2002-08-15 2004-03-18 Yunqing Liu Formulation nanopharmaceutique et son procede de preparation
ATE549014T1 (de) 2006-09-05 2012-03-15 Q P Corp Prostaglandin-fettemulsion, verfahren zu ihrer herstellung, verfahren zu ihrer stabilisierung und emulgierendes mittel
CN101843594B (zh) * 2010-05-11 2011-05-25 重庆药友制药有限责任公司 一种注射用前列地尔冻干乳剂及其制备方法
CN109394704B (zh) 2018-11-27 2021-09-17 西安力邦肇新生物科技有限公司 一种前列腺素e1甲酯注射用冻干制剂及制备和应用
CN109288848A (zh) * 2018-11-27 2019-02-01 西安力邦肇新生物科技有限公司 前列腺素e1甲酯在制备扩张血管药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4950124A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-09-27 1974-05-15
US3927213A (en) * 1973-07-10 1975-12-16 American Home Prod Prostaglandin E{HD 2 {B and derivatives for reducing the side effects of anti-inflammatory agents
US4190669A (en) * 1976-03-08 1980-02-26 The Regents Of The University Of Michigan Method for treating psoriasis
JPS5391110A (en) * 1977-01-20 1978-08-10 Yamanouchi Pharmaceut Co Ltd Novel drug composition for rectal infusion
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
JPS56127308A (en) * 1980-03-11 1981-10-06 Green Cross Corp:The Blood-coagulation factor 8 pharmaceutical
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
US4443473A (en) * 1981-06-30 1984-04-17 The Procter & Gamble Company Carbamate derivatives
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤

Also Published As

Publication number Publication date
CA1212324A (en) 1986-10-07
JPH0157096B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-12-04
ES532561A0 (es) 1985-06-01
US4849451A (en) 1989-07-18
EP0132027B1 (en) 1988-08-10
DE3473227D1 (en) 1988-09-15
JPS59216820A (ja) 1984-12-06
EP0132027A1 (en) 1985-01-23

Similar Documents

Publication Publication Date Title
ES8505650A1 (es) Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1
KR830006228A (ko) 이미다졸 유도체의 제조방법
FR2383907A1 (fr) Procede de preparation de derives de l'acide acetique et derives obtenus par ce procede
FR2372817A1 (fr) Derives d'acides thiazolidinecarboxyliques et d'acides apparentes, utiles comme agents anti-hypertension
FR2361892A1 (fr) Esters et amides des acides pyrimido(4,5-b)quinolein-4(3h)-one-2-carboxyliques, en tant qu'agents anti-ulceres
SE8604950D0 (sv) Dementia-improving and therapeutic agents
FR2365341A1 (fr) Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique
ES449096A1 (es) Un procedimiento para la preparacion de 11-desoxi-16-ariloxi-omega-tetranorprostaglandinas.
ES393913A1 (es) Procedimiento de preparacion de nuevos derivados de acido fenilacetico, racemicos u opticamente activos.
SE7710916L (sv) Anvendning av ortofosforsyraestrar i vattenhaltiga metallbearbetningsvetskor
FR2455609A1 (fr) 24-24-difluoro-25-hydroxycholecalciferol
GB1097531A (en) Improvements in or relating to the preparation of cyclopentane derivatives
GB1097532A (en) Improvements in or relating to the preparation of cyclopentane derivatives
KR840004422A (ko) 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법
DK0470275T3 (da) Hudhvidgørende kosmetisk præparat
ES516158A0 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
KR920701232A (ko) 신규 9α-히드록시-3-옥소-4,24(25)-스티그마스타디엔-26-산 유도체, 이의 제조법 및 이를 함유하는 약학 조성물
GB1298005A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2359133A1 (fr) Procede de preparation de (vinyl 2,2-disubstitue)-g-butyrolactones
FR2374316A1 (fr) Derives de morpholine utilisables comme fongicides
KR850000026A (ko) 바이 사이클로(3.2.1)-옥탄 카르복실산의 제조방법 및 조성물
SE8800846D0 (sv) Optiskt aktiva oxo-isoindolinderivat
BE896098A (fr) Procede de modulation de la reponse immunitaire avec des dibenzocycloheptenylidenes
DE3481707D1 (de) 7-alpha-substituierte 3-oxo-17alpha-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980302